Earnings History Data for Xencor, Inc. (XNCR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Xencor, Inc.

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-02-2024	AH		XNCR	Xencor, Inc.	1,490	-0.31	0.36	-0.20	Xencor GAAP EPS of -$0.31 misses by $0.32, revenue of $44.7M misses by $30.01M [2/27/2024 4:05 PM]	22.80	-3.72 (-14.05%)	24.41	-2.11 (-7.96%)	16.49 - 33.38	3,073,282	740,000	3,877
Xencor GAAP EPS of -$0.31 misses by $0.32, revenue of $44.7M misses by $30.01M [2/27/2024 4:05 PM] Xencor slips as Piper cuts citing patient death in cancer study [2/28/2024 1:37 PM]
07-11-2023	AH		XNCR	Xencor, Inc.	1,120	-0.40	-0.77	-0.55	Xencor GAAP EPS of -$0.40 beats by $0.31, revenue of $59.16M beats by $29.13M [11/7/2023 4:39 PM]	17.26	-1.28 (-6.90%)	18.97	0.43 (2.32%)	16.72 - 38.20	589,960	370,000	11,998
Xencor GAAP EPS of -$0.40 beats by $0.31, revenue of $59.16M beats by $29.13M [11/7/2023 4:39 PM] Xencor falls after royalty sale to Canada’s OMERS [11/8/2023 3:07 PM]
03-08-2023	AH		XNCR	Xencor, Inc.	1,450	-0.37	-0.91	-0.57	Xencor GAAP EPS of -$0.37 beats by $0.43, revenue of $45.5M beats by $19.22M [8/3/2023 4:32 PM]	24.16	0.81 (3.47%)	23.56	0.21 (0.90%)	23.24 - 38.20	466,104	240,000	12,989
Xencor GAAP EPS of -$0.37 beats by $0.43, revenue of $45.5M beats by $19.22M [8/3/2023 4:32 PM]
08-05-2023	AH	4:00 PM ET (May 8)	XNCR	Xencor, Inc.	1,660	-1.02	-0.75	0.39	Xencor GAAP EPS of -$1.02 misses by $0.36, revenue of $18.96M misses by $7.93M [5/8/2023 4:48 PM]	26.88	-0.46 (-1.68%)	27.00	-0.34 (-1.24%)	19.35 - 38.20	292,946	270,000	303
Xencor GAAP EPS of -$1.02 misses by $0.36, revenue of $18.96M misses by $7.93M [5/8/2023 4:48 PM]
23-02-2023	AH	4:00 PM ET (Feb 23)	XNCR	Xencor, Inc.	2,120	-0.20	-0.83	1.21	Xencor GAAP EPS of -$0.20 beats by $0.60, revenue of $21.6M beats by $2.36M [2/23/2023 4:55 PM]	33.17	-1.01 (-2.95%)	34.18	0.0 (0.00%)	19.35 - 38.20	279,316	360,000	11,490
Xencor GAAP EPS of -$0.20 beats by $0.60, revenue of $21.6M beats by $2.36M [2/23/2023 4:55 PM]
07-11-2022	AH	4:00 PM ET (Nov 7)	XNCR	Xencor, Inc.	1,620	-0.55	-0.77	-0.69	Xencor GAAP EPS of -$0.55 beats by $0.13, revenue of $27.3M beats by $6.25M [11/7/2022 4:13 PM]	29.33	2.37 (8.79%)	26.96	0.0 (0.00%)	19.35 - 42.30	429,062	310,000	10,123
Xencor GAAP EPS of -$0.55 beats by $0.13, revenue of $27.3M beats by $6.25M [11/7/2022 4:13 PM] Xencors IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study [Nov-07-22 04:01PM] Xencor Reports Third Quarter 2022 Financial Results [Nov-07-22 04:01PM]
03-08-2022	AH	4:00 PM ET (Aug 3)	XNCR	Xencor, Inc.	1,740	-0.57	-0.45	0.87	Xencor GAAP EPS of -$0.57 misses by $0.10, revenue of $30.18M misses by $3.83M [8/3/2022 4:14 PM]	29.62	0.05 (0.17%)	3.92	-0.40 (-9.26%)	19.36 - 43.61	405,057	240,000	51,552
Xencor GAAP EPS of -$0.57 misses by $0.10, revenue of $30.18M misses by $3.83M [8/3/2022 4:14 PM] Xencor stock down 7% on Q2 result miss [8/4/2022 9:11 AM] Xencor Reports Second Quarter 2022 Financial Results [Aug-03-22 04:01PM] Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies [Aug-02-22 06:30AM]
05-05-2022	AH	4:00 PM ET (May 5)	XNCR	Xencor, Inc.	1,550	0.39	-0.70	-0.04	Xencor GAAP EPS of $0.39 beats by $1.03, revenue of $85.5M beats by $59.33M [5/5/2022 5:05 PM]	25.76	1.01 (4.08%)	25.76	0.0 (0.00%)	24.30 - 43.61	475,296	320,000	9,512
Xencor GAAP EPS of $0.39 beats by $1.03, revenue of $85.5M beats by $59.33M [5/5/2022 5:05 PM] Esperion (ESPR) Q1 Earnings Beat on Robust Demand for Drugs [May-04-22 10:52AM] 3 Best Profitable Stocks to Buy Using Net Income Ratio [May-05-22 08:45AM] Sarepta (SRPT) Q1 Earnings Beat, DMD Drugs' Sales Robust [May-05-22 09:31AM] Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y [May-05-22 11:26AM] United Therapeutics (UTHR) Q1 Earnings & Sales Beat, Stock Up [May-05-22 11:12AM] Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates [May-05-22 11:07AM] Xencor Reports First Quarter 2022 Financial Results [May-05-22 04:01PM] Xencor (XNCR) Beats Q1 Earnings and Revenue Estimates [May-05-22 05:25PM] Zacks.com featured highlights Xencor, Encore Wire and Silvergate Capital [May-06-22 05:38AM] Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues [May-06-22 10:24AM]
23-02-2022	AH		XNCR	Xencor, Inc.	1,870	1.21	0.47	-0.24	Xencor GAAP EPS of $1.21 beats by $1.11, revenue of $154.02M beats by $77.73M [2/23/2022 4:27 PM]	31.96	0.48 (1.51%)	31.48	0.0 (0.00%)	0.0 - 0.0	166,627	0	1,751
Xencor GAAP EPS of $1.21 beats by $1.11, revenue of $154.02M beats by $77.73M [2/23/2022 4:27 PM] Shareholders in Xencor (NASDAQ:XNCR) have lost 35%, as stock drops 4.0% this past week [Feb-22-22 12:24PM] Xencor Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-23-22 04:01PM] Xencor (XNCR) Q4 Earnings and Revenues Beat Estimates [Feb-23-22 05:35PM]
08-11-2021	AH	4:00 PM ET (Nov 8)	XNCR	Xencor, Inc.	2,490	-0.69	-0.75	-0.22	Xencor EPS beats by $0.07, beats on revenue [11/8/2021 4:07 PM]	38.47	-2.13 (-5.25%)	39.35	-1.25 (-3.08%)	30.12 - 58.34	210,835	190,000	812
Xencor EPS beats by $0.07, beats on revenue [11/8/2021 4:07 PM] Ironwood (IRWD) Q3 Earnings Top, Sales Hurt by Lower Price [Nov-05-21 10:35AM] Xencor Reports Third Quarter 2021 Financial Results and Announces Encouraging Preliminary Data from Ongoing Phase 1 Study of Potency-reduced IL15-Fc Cytokine, XmAb306 [Nov-08-21 04:01PM] Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-21 05:15PM] Xencor, inc (XNCR) Q3 2021 Earnings Call Transcript [Nov-08-21 09:30PM] Novartis Dumps Another Bispecific Candidate From Xencor Deal [Nov-09-21 01:14PM]
04-08-2021	AH	4:00 PM ET (Aug 4)	XNCR	Xencor, Inc.	1,790	0.87	-0.61	-0.61	Xencor EPS beats by $1.48, beats on revenue [8/4/2021 4:38 PM]	32.23	1.17 (3.77%)	31.06	0.0 (0.00%)	29.51 - 58.34	205,993	170,000	7,145
Xencor EPS beats by $1.48, beats on revenue [8/4/2021 4:38 PM] Xencor Reports Second Quarter 2021 Financial Results [Aug-04-21 04:01PM] Xencor (XNCR) Q2 Earnings and Revenues Surpass Estimates [Aug-04-21 05:35PM] Xencor, inc (XNCR) Q2 2021 Earnings Call Transcript [Aug-04-21 11:31PM]
05-05-2021	AH	4:00 PM ET (May 5)	XNCR	Xencor, Inc.	2,470	-0.04	-0.76	-0.14	Xencor EPS beats by $0.70, beats on revenue [5/5/2021 4:04 PM]	39.72	-1.04 (-2.55%)	39.72	0.0 (0.00%)	27.38 - 58.34	281,886	190,000	12,754
Xencor, Inc. to Host Earnings Call [May-05-21 02:45PM] Xencor Reports First Quarter 2021 Financial Results [May-05-21 04:01PM] Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 05:25PM] Xencor Inc (XNCR) Q1 2021 Earnings Call Transcript [May-06-21 02:00PM]
23-02-2021	AH	4:00 PM ET (Feb 23)	XNCR	Xencor, Inc.	2,930	-0.24	-0.54	-0.47	Xencor EPS beats by $0.12, beats on revenue [2/23/2021 4:29 PM]	48.38	0.03 (0.06%)	48.71	0.36 (0.74%)	19.35 - 58.34	210,097	200,370	9,289
Xencor EPS beats by $0.12, beats on revenue [2/23/2021 4:29 PM] Recap: Xencor Q4 Earnings [Feb-23-21 04:22PM] Xencor Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-23-21 04:01PM] Xencor, Inc. to Host Earnings Call [Feb-23-21 02:30PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	XNCR	Xencor, Inc.	2,270	-0.22	-0.22	-0.18	Xencor EPS misses by $0.01, misses on revenue [11/5/2020 4:29 PM]	37.82	-3.38 (-8.20%)	41.20	0.0 (0.00%)	19.35 - 43.90	212,644	209,447	3,120

04-08-2020	AH		XNCR	Xencor, Inc.	1,720	-0.61	-0.56	-0.30	Xencor EPS misses by $0.07, beats on revenue [8/4/2020 4:20 PM]	30.71	-0.21 (-0.68%)	30.92	0.0 (0.00%)	19.35 - 46.33	173,773	247,552	3,699